NE3107 in Adults With Neurological Symptoms of Long COVID

NCT06847191 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Long COVID

Interventions

DRUG: NE3107
DRUG: Placebo

Sponsor

BioVie Inc.